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Summary
Type VI Secretion Systems (T6SS) have been studied primarily in the context of pathogenic
bacterial-host interactions. Recent data suggest, however, that these versatile secretion systems
may also function to promote commensal or mutualistic relationships between bacteria and
eukaryotes, or to mediate cooperative or competitive interactions between bacteria.
Introduction
The Type VI Secretion System (T6SS) was recognized as a distinct class of bacterial protein
secretion system in 2006 with two papers from the Mekalanos laboratory. The first study
(Pukatzki et al., 2006) found that the IcmF-associated homologous protein (IAHP) gene
cluster of Vibrio cholerae was required for secretion of the proteins Hcp and VgrG and for
cytotoxicity toward Dictyostelium amoebae. The second study (Mougous et al., 2006)
included structural data that indicated the formation of a secretion apparatus, and provided
evidence that the apparatus was functional during chronic lung infection of Pseudomonas
aeruginosa in cystic fibrosis patients. Both studies described Type VI Secretion (T6S) in the
context of pathogenesis – indeed, the T6SS-encoding genes of V. cholerae were named
virulence associated secretion (vas) genes.
Putative T6SS-encoding gene clusters have now been identified in over one fourth of
sequenced Gram-negative bacterial genomes (Bingle et al., 2008; Persson et al., 2009;
Pukatzki et al., 2009). Many of these T6SS-containing bacteria are known pathogens, and
T6SSs have been experimentally shown to play a role in virulence in several cases (see
Bingle et al., 2008 and Pukatzki et al., 2009 for specific references). In Burkholderia mallei,
T6S is required for virulence in a hamster model and promotes giant multinucleated cell
formation and intracellular spread in macrophage cell lines (Burtnick et al. 2010). In
Burkholderia cenocepacia, Hcp is required for host cell actin remodeling and confers
resistance to predation by Dictyostelium amoebae, and Tn insertions in T6SS-encoding
genes were associated with virulence defects in in vivo chronic lung infection models.
Deletion of genes encoding T6SS components in Edwardsiella tarda caused a virulence
defect in a blue gourami fish host. And when produced inside HeLa cells, Hcp of
Aeromonas hydrophila induced apoptosis and T6S contributed to virulence of this pathogen
in mice. In some cases, putative T6SS components contribute to virulence, but in a manner
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that appears to be independent of other T6SS components. In Agrobacterium tumefaciens,
for example, Hcp appeared to contribute to tumorigenesis of potato tuber disks, but deletion
of the rest of the T6SS-encoding genes had no effect. Similarly, homologues of T6SS-
encoding genes in Francisella tularensis were required for growth within macrophages and
virulence in mice, but the secretion of those gene products appeared not to require the other
putative T6SS-encoding genes (Barker et al 2009). The Agrobacterium and Francisella
studies highlight the need for a better understanding of what exactly constitutes a T6SS and
how T6SSs and their effectors function mechanistically.
The importance of T6S in pathogenesis is becoming increasingly clear. However, many
bacteria with genomes encoding putative T6SSs are not known to be pathogens or even
symbionts, suggesting T6S may also function in nonpathogenic bacteria-host interactions or
in interactions not involving eukaryotic partners. Several papers, including three published
in Cell Host & Microbe in the last year, highlight the potential diversity of functions for
T6S.
T6SSs as virulence factors
Understanding the mechanisms underlying T6S and its role in pathogenesis has been
challenging because of the lack of identified effector proteins. Although in vitro studies
identified two proteins that were secreted in a T6SS-depndent manner, Hcp and VgrG, each
was required for the secretion of the other, suggesting that both might be part of the
secretion apparatus and not bona fide effectors. V. cholerae produces three VgrG proteins,
VgrG-1, VgrG-2, and VgrG-3. These proteins share a conserved N-terminal domain but
contain divergent C-termini. The C-terminal domain of VgrG-1 has predicted similarity to
the actin crosslinking domain (ACD) of RtxA, a large RTX-containing toxin of V. cholerae.
Incubation of purified recombinant VgrG-1 with eukaryotic cell lysates showed that VgrG-1
crosslinks actin, and incubation of J774 cells with various T6SS mutant and parental V.
cholerae strains showed that VgrG-1 and other core T6SS components (VasK and Hcp)
were necessary to induce actin crosslinking in host cells (Pukatzki et al., 2007). These data
suggested an actin crosslinking effector function for VgrG-1, but the requirement of VgrG-1
for secretion confounded its classification as an effector.
Ma et al. (2009) aimed to disentangle the effector and secretory functions of VgrG-1 by
comparing V. cholerae strains that contained deletions of either the entire vgrG-1 gene or
only the region encoding the C-terminal ACD. Their data showed that the ACD was
required for actin crosslinking and cytotoxicity toward J774 cells and Dictyostelium, but not
for T6SS-dependent protein secretion. To determine if the ACD was translocated into host
cells, J774 cells were infected with V. cholerae strains containing a ß-lactamase reporter
fused to or replacing the ACD of VgrG-1. The reporter proteins were detected inside host
cells as long as the N-terminal portion of VgrG-1 and known core T6SS components were
intact. Together, these data indicated that the conserved N-terminal portion of VgrG-1 is part
of the secretion system proper, while the C-terminal ACD functions as an effector. This
work was the first to definitively and specifically identify a T6S effector. Interestingly,
previous work had noted that several other bacteria encode VgrG orthologues containing
divergent C-terminal extensions with diverse predicted functions (Pukatzki et al., 2007).
Whether these orthologues represent true effectors, and what their specific functions are,
remains to be determined. Identification of additional effectors, their targets and
mechanisms of action, and their conservation among T6SSs of different bacteria will be
important for understanding the role of T6S in pathogenesis and other types of interactions.
The second important finding to come out of the Ma et al. (2009) study was that T6S only
occurs after the bacteria are internalized and that VgrG-1-mediated actin crosslinking
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inhibits further phagocytic activity. While studies of other bacteria, including Burkholderia
pseudomallei, B. cenocepacia, and Salmonella enterica serovar Typhimurium (S.
Typhimurium), had also found that expression of T6SS-encoding genes was induced upon
uptake into host cells, the resulting impairment of further phagocytic activity indicated by
the Ma et al. study was an important new finding. The authors hypothesized that actin
crosslinking and resultant inhibition of phagocytosis by early-colonizing bacteria may
protect additional “bystander” or late-colonizing bacteria from phagocytosis, i.e., that T6S
may mediate altruistic behavior among bacteria – an intriguing idea.
Having shown that translocation of the VgrG-1 ACD requires endocytosis and results in
actin crosslinking in host cells in vitro, Ma and Mekalanos went on to investigate the
mechanism of action of VgrG-1 and the T6SS in vivo. They first compared fluid
accumulation and gene expression in the intestines of mice infected with various T6SS
mutant and rtxA deletion strains (Ma and Mekalanos, 2010). (In both Ma et al., 2009 and Ma
and Mekalanos, 2010, parental strains were ΔhlyAΔhapA, since these genes encode
accessory toxins that would mask effects of T6S on mammalian cells. In some cases, rtxA
was also deleted to avoid confounding results, since RtxA also crosslinks actin.) Fluid
accumulation and monocyte infiltration in the intestinal lumen and expression of several
inflammation-associated genes were decreased in the T6SS mutant-infected mice compared
with those infected with parental strains. These phenotypes required not only the core
components of the T6SS, but also the ACD of VgrG-1, providing in vivo evidence for the
effector function of the ACD. In addition, crosslinked actin was detected in intestines of
mice infected with parental strains, but not those infected with strains carrying deletions in
any of the T6SS-encoding genes tested. Together, these results suggest that the ACD of
VgrG-1 is translocated into and cross-links actin in host cells in vivo, and that this activity
leads to inflammation and pathology in the intestines of mice. Ma and Mekalanos took their
study a step further to test the hypothesis that early-colonizing bacteria use their T6SSs to
facilitate colonization by late-colonizing bacteria. They first “pre-infected” mice with
bacteria producing either wild type VgrG-1 or ΔACD VgrG-1, then “super-infected” four
hours later with either the same or the opposite strain. They found that pre-infection with
bacteria producing wild type VgrG-1, but not with bacteria producing ΔACD VgrG-1,
allowed super-infected ΔACD VgrG-1-producing bacteria to grow in the mouse intestines to
levels indistinguishable from that of wild type VgrG1-producing bacteria. The data suggest
that initial infection by wild type VgrG1-producing bacteria creates a favorable within-host
environment for the growth of V. cholerae. Whether this environment is favorable because
the phagocytic cells have been inactivated or because of some other aspect of the VgrG1-
dependent altered inflammatory response remains to be determined. Nonetheless, the results
suggest that the V. cholerae T6SS may function as a virulence factor in both the immediate
sense of causing inflammation, and in a longer-term, or ultimate, sense of contributing to
within-host growth and probably subsequent transmission.
It is worth noting that the use of Dictyostelium to study V. cholerae pathogenesis was pivotal
to the discovery of T6S as a new class of secretion system with a role in virulence. The use
of invertebrate models for mimicking human infection processes has been variably
successful and a topic of debate. For pathogens with environmental habitats, however, it is
likely that some virulence factors used for human infection evolved from and/or still
function as factors important during interactions with diverse organisms that facilitate
environmental survival (Matz and Kjelleberg, 2005; Matz et al., 2008). For V. cholerae, a
role for T6S during interactions with environmental amoeba seems likely based on the clear,
measurable phenotype of the T6S mutant in Dictyostelium. The importance of T6S during
infection of mammals by V. cholerae is less obvious and may have been missed completely
if not for the use of Dictyostelium, since T6S-dependent phenotypes in mammalian hosts or
cell lines require the use of V. cholerae strains with deletions in genes encoding accessory
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toxins (hlyA, hapA, and/or rtxA). As with V. cholerae, many other T6SS-possessing bacterial
species can be found free-living in the environment or in association with non-mammalian
hosts. While many of these bacteria are studied most intensively due to their potential as
facultative pathogens of humans, awareness of their environmental interactions as part of the
disease cycle is important and rising. For example, it is clear that understanding the
interaction between Yersinia pestis and fleas is critical to understanding how this pathogen
causes plague in humans. Burkholderia pseudomallei, a soil saprotroph, is being studied in
amoeba, nematodes, a larval insect, and tomato plants with the hope that understanding
these interactions will shed light on the mechanisms it uses to cause human melioidosis.
Although some factors may be host-specific, it seems likely that others are not and their
discovery may be facilitated by the use of non-mammalian models.
T6SS as anti-pathogenesis factors
While several studies support a role for T6S in pathogenesis, a few support an alternate
view: that T6S may function to limit bacterial replication or virulence, pushing interactions
with hosts away from pathogenesis and toward a commensal or mutualistic state. In fact, one
of the first T6SS mutants characterized was one involved in a mutualistic relationship.
Rhizobium leguminosarum colonizes the roots of leguminous plants, forming nodules in
which it fixes nitrogen. The Rhizobium-plant interaction is highly specific and certain
variants of R. leguminosarum form nitrogen fixing nodules only with plants in the clover
group. Bladergroen et al. (2003) found that a strain with a deletion mutation in the imp gene
cluster (now known to encode a T6SS) was also able to form functional nitrogen-fixing
nodules on pea plants. Their data indicated that the imp gene cluster (i.e., the T6SS) was
involved in secretion of proteins that block infection of pea plants by R. leguminosarum,
thus determining host-specificity of the Rhizobium-plant interaction.
Another example of an anti-pathogenesis role for the T6SS comes from studies with S.
Typhimurium. Parsons and Heffron (2005) identified a locus, sciS (now known to encode
part of a T6SS) that, when mutated, results in increased replication of S. Typhimurium in
macrophages at 24 hours post-inoculation and increased virulence in a mouse model,
suggesting the role of sciS, and hence T6SS, in S. Typhimurium is to limit virulence and
therefore contribute to long-term colonization.
A recent study of Helicobacter hepaticus further indicates that T6S can function to limit
within-host growth and virulence. H. hepaticus is a common symbiont and possible
facultative pathogen of rodent gastrointestinal tracts. Using confocal microscopy and
gentamicin protection assays, Chow and Mazmanian (2010) showed that H. hepaticus
adherence to and internalization by mouse intestinal epithelial cell (IEC) lines was increased
for a T6SS mutant compared with the wild type strain. Furthermore, colonization of mouse
colon and invasion of IECs in vivo, as determined by 16S qPCR of colon tissue and bacterial
CFU counts from gentamicin-treated purified IECs, were increased in the T6SS mutant.
Chow and Mazmanian then asked whether the T6SS could reduce the inflammation caused
by H. hepaticus under experimentally induced dysbiosis. They defined dysbiosis as an
imbalance in the composition of the host-associated microbiota, which can cause some
symbiotic bacteria to have pathogenic effects. To produce a model of dysbiosis, they
reconstituted T and B cell deficient mice with naïve CD4+CD45Rb high T cells (i.e., T cells
from germ-free mice, such that they have not been exposed to bacterial antigens). These T
cells react pathogenically to certain gut bacteria, including H. hepaticus, whereas
“experienced” T cells from mice with normal gut microbiota tolerate these bacteria. In this
dysbiosis model, the T6SS mutant showed higher colonization and induced a stronger
inflammatory response compared with wild type H. hepaticus. The authors concluded that
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the T6SS functions to limit inflammation caused by H. hepaticus, thus possibly reducing
negative impacts of dysbiosis on the host.
The data presented by Chow and Mazmanian are compelling. Important next steps include
the identification of effectors involved in limiting pathogenesis or mediating mutualism,
since the T6S-dependent translocation of effectors into host cells has so far only been
explicitly demonstrated in pathogenic interactions. Identification of effectors involved in
non-pathogenic interactions will also help determine if the nature of a T6SS-mediated
interaction, whether antagonistic or beneficial, is dictated by effectors specific to different
types of interactions, or alternatively whether orthologous effectors in different bacteria can
mediate both positive and negative interactions. A greater mechanistic understanding would
help distinguish whether pathogenic versus non-pathogenic effects result from
fundamentally different interactions at the molecular level, or are simply a result of
differences in the number of bacteria present within a host. For example, in the H. hepaticus
system, does the T6SS prevent inflammation by altering host cell response to the presence of
the bacterium, or simply by limiting the number of bacteria?
Differentiating between pathogenic and non-pathogenic interactions can be complicated by
the fact that the distinction is often ambiguous and can depend on the context and time
frame of the interaction. Time frame can be particularly important since factors that reduce
acute harm to a host, as seen for T6S in S. Typhimurium, may in fact promote transmission
by enabling a latent sit-and-wait phase. Detection of these various effects will depend on the
design and scope of the study. The H. hepaticus system illustrates the importance of
ecological context, since the pathological effects of the bacterium are dependent on prior
exposure of the host to gut microflora. For H. hepaticus, translating differences in
inflammation-associated gene expression to pathology will help elucidate how the T6SS of
H. hepaticus ultimately maintains a non-pathogenic relationship with the host. Studies
incorporating both immediate and long-term effects of T6S on hosts, as discussed for the Ma
and Mekalanos pathogenesis study, above, will be important in further distinguishing
antagonistic from harmless or mutualistic effects of T6S.
T6SS in interbacterial interactions
New data present the intriguing possibility that T6S may function to mediate interactions
between bacteria rather than between bacteria and their eukaryotic hosts. A review of
Myxococcus xanthus extracellular biology alluded to a role for T6S in the formation of
fruiting bodies, suggesting T6S may be used for intraspecies microbial cooperation
(Konovalova et al. 2010). Alternatively, recent work by Hood et al. (2010) suggests that
T6SSs may mediate antagonistic interactions between bacteria. By comparing secretomes of
Pseudomonas aeruginosa strains with either disruption or constitutive over-expression of
the H1-T6SS gene cluster, the group identified three putative T6SS effectors, which they
named Tse1-3 (type six effector 1-3). All three putative effectors were secreted into culture
supernatants in a manner requiring the presence of the core T6S components Hcp1 and
ClpV1 and deletion of genes encoding negative regulators of H1-T6S (retS which encodes a
global regulator that represses transcription of H1-T6SS genes and/or pppA, which encodes
a serine-threonine phosphatase that post-translationally represses T6S). However, none of
the tse genes was required for the secretion of Hcp, indicating that they are not part of the
secretion apparatus and may function solely as effectors.
One of the putative effectors, Tse2, was toxic to yeast, mammalian cells, and bacteria when
produced intracellularly. The inability to introduce a deletion mutation in a small open
reading frame immediately downstream of tse2 if tse2 was intact (but not if it was also
deleted) caused the authors to suspect that the downstream gene, which they named tsi2,
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encoded a protein conferring immunity to the toxic effects of tse2. In support of this
hypothesis, Tsi2 interacted with Tse2 in co-immunoprecipitation experiments, and
production of Tsi2 within cells relieved toxicity of Tse2 for both eukaryotes (yeast and
mammalian cells) and bacteria.
While intracellular production of Tse2 resulted in toxicity for all cells tested, subsequent
experiments exposing target cells to tse2-expressing P. aeruginosa yielded a surprising
result: eukaryotic cells were unaffected. Thus, although Tse2 was secreted by P. aeruginosa
in a T6S-dependent manner, it appeared not to be translocated into eukaryotic hosts, even
when P. aeruginosa was phagocytosed, suggesting that eukaryotes are not the true target of
the Tse2 effector. By contrast, under certain culture conditions, the growth of bacterial target
cells lacking tse2/tsi2 was severely inhibited by co-culture with Tse2/Tsi2 expressing
bacteria. Expression of tsi2 in the target bacteria relieved the inhibition. Although Hood et
al. did not show that Tse2 was translocated into target bacteria, the data suggest that Tse2 is
a T6S effector that mediates competitive interactions among bacteria.
The study by Hood et al., which used strains of P. aeruginosa engineered to express their
T6SSs constitutively and in which interbacterial inhibition occurred only when bacteria were
grown on a solid support, raises many questions. When and where might the bacteria deploy
their T6SSs to inhibit the growth of neighboring bacteria in nature? Do these systems
mediate in both intra- and inter-species inhibition? Can they distinguish self from non-self
target bacteria? Do T6SSs encoded by other bacteria function as inter-bacterial competition
systems? If so, do they have Tse2/Tsi2 orthologues with different specificities? Do the
T6SSs that target bacteria (and therefore must translocate proteins across two bacterial
membranes) differ from those that target eukaryotic cells (and therefore must translocate
proteins across only one plasma membrane)? Answering these and other questions will be
critical to gaining a complete understanding of T6SSs and their potential.
T6SS as mediators of multiple interactions in diverse bacteria
The studies reviewed here showed that T6S functions in pathogenesis in several bacteria, in
anti-pathogenesis in a few others, and in inter-bacterial interactions in a third case. However,
several bacterial genomes contain multiple T6S-encoding gene clusters that appear not to be
paralogues, suggesting the possibility for diverse functions. P. aeruginosa has three
predicted T6S-encoding gene clusters, Y. pestis and Photorhabdus luminescens each have
four, and B. mallei, B. thailandensis, and B. pseudomallei have four, five, and six,
respectively. Many bacteria with the potential to produce several T6SSs have multiple hosts
or survive in diverse environmental conditions. Y. pestis interacts intimately with both
insects and mammals, and incidentally, at least one of its T6SSs is regulated by changes in
temperature comparable to the body temperatures of fleas and mammals (Robinson et al.
2009). P. aeruginosa is both an environmental microbe and facultative pathogen of humans
and can persist for years in the lungs of cystic fibrosis patients. Similarly, B. pseudomallei is
an environmental soil microbe and facultative human pathogen, causing infections that
reportedly can persist for more than 60 years. Given the mounting evidence for divergent
functions of the T6SS, the idea that multiple T6SSs within individual bacterial species could
mediate various types of interactions with diverse hosts, predators, cooperators or
competitors is an enticing possibility that demands further study.
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Figure 1. Multifunctionality of Type VI Secretion
As highlighted by three papers published in the last year in Cell Host & Microbe, Type VI
Secretion Systems have been implicated in virulence, commensalism or symbiosis, and
interbacterial competition.
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